1. Home
  2. FEIM vs TLSA Comparison

FEIM vs TLSA Comparison

Compare FEIM & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Frequency Electronics Inc.

FEIM

Frequency Electronics Inc.

HOLD

Current Price

$85.14

Market Cap

722.9M

Sector

Industrials

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

BUY

Current Price

$1.11

Market Cap

145.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
FEIM
TLSA
Founded
1961
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
722.9M
145.1M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
FEIM
TLSA
Price
$85.14
$1.11
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
★ $95.50
$7.99
AVG Volume (30 Days)
365.1K
★ 599.2K
Earning Date
09-10-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.41
N/A
Revenue
★ $63,227,000.00
N/A
Revenue This Year
$30.80
N/A
Revenue Next Year
$26.18
N/A
P/E Ratio
$208.44
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$26.05
$0.76
52 Week High
$89.76
$2.33

Technical Indicators

Market Signals
Indicator
FEIM
TLSA
Relative Strength Index (RSI) 60.67 56.88
Support Level $48.49 $0.90
Resistance Level $89.68 $1.20
Average True Range (ATR) 4.17 0.10
MACD -0.12 0.02
Stochastic Oscillator 53.24 79.00

Price Performance

Historical Comparison
FEIM
TLSA

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is a world leader in precision time and frequency generation technology, which is incorporated into commercial and U.S. Government satellites, Command, Control, Communication, Computer, Intelligence, Surveillance and Reconnaissance, and Electronic Warfare systems. Its technology is used for a wide range of space and non-space applications. The company has two segments FEI-NY, and FEI-Zyfer. Majority of revenue come from FEI-NY which provides precision time, frequency generation and synchronization products and subsystems that are found on-board satellites, in ground-based communication systems and imbedded in mobile platforms operated by the U.S. military.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: